176 related articles for article (PubMed ID: 20044060)
1. Mothers' preferences and willingness to pay for vaccinating daughters against human papillomavirus.
Brown DS; Johnson FR; Poulos C; Messonnier ML
Vaccine; 2010 Feb; 28(7):1702-8. PubMed ID: 20044060
[TBL] [Abstract][Full Text] [Related]
2. Mothers' preferences and willingness to pay for HPV vaccines in Vinh Long Province, Vietnam.
Poulos C; Yang JC; Levin C; Van Minh H; Giang KB; Nguyen D
Soc Sci Med; 2011 Jul; 73(2):226-34. PubMed ID: 21733609
[TBL] [Abstract][Full Text] [Related]
3. Mothers' intention for their daughters and themselves to receive the human papillomavirus vaccine: a national study of nurses.
Kahn JA; Ding L; Huang B; Zimet GD; Rosenthal SL; Frazier AL
Pediatrics; 2009 Jun; 123(6):1439-45. PubMed ID: 19482752
[TBL] [Abstract][Full Text] [Related]
4. Attitudes of mothers in Da Nang, Vietnam toward a human papillomavirus vaccine.
Dinh TA; Rosenthal SL; Doan ED; Trang T; Pham VH; Tran BD; Tran VD; Phan GA; Chu HK; Breitkopf CR
J Adolesc Health; 2007 Jun; 40(6):559-63. PubMed ID: 17531763
[TBL] [Abstract][Full Text] [Related]
5. The clinical benefit and cost-effectiveness of human papillomavirus vaccination for adult women in the Netherlands.
Bogaards JA; Coupé VM; Meijer CJ; Berkhof J
Vaccine; 2011 Nov; 29(48):8929-36. PubMed ID: 21945961
[TBL] [Abstract][Full Text] [Related]
6. Quadrivalent human papillomavirus vaccine.
Barr E; Tamms G
Clin Infect Dis; 2007 Sep; 45(5):609-7. PubMed ID: 17682997
[TBL] [Abstract][Full Text] [Related]
7. Preventing cervical cancer through human papillomavirus vaccination: perspective from focus groups.
Wong LP
J Low Genit Tract Dis; 2009 Apr; 13(2):85-93. PubMed ID: 19387128
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of the introduction of a quadrivalent human papillomavirus vaccine in France.
Bergeron C; Largeron N; McAllister R; Mathevet P; Remy V
Int J Technol Assess Health Care; 2008; 24(1):10-9. PubMed ID: 18218164
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.
de Kok IM; van Ballegooijen M; Habbema JD
J Natl Cancer Inst; 2009 Aug; 101(15):1083-92. PubMed ID: 19571256
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology, clinical manifestations, and recent advances in vaccination against human papillomavirus.
Broomall EM; Reynolds SM; Jacobson RM
Postgrad Med; 2010 Mar; 122(2):121-9. PubMed ID: 20203463
[TBL] [Abstract][Full Text] [Related]
11. Girls' preferences for HPV vaccination: a discrete choice experiment.
de Bekker-Grob EW; Hofman R; Donkers B; van Ballegooijen M; Helmerhorst TJ; Raat H; Korfage IJ
Vaccine; 2010 Sep; 28(41):6692-7. PubMed ID: 20708696
[TBL] [Abstract][Full Text] [Related]
12. Acceptability of the human papillomavirus vaccine among Latina mothers.
Bair RM; Mays RM; Sturm LA; Zimet GD
J Pediatr Adolesc Gynecol; 2008 Dec; 21(6):329-34. PubMed ID: 19064226
[TBL] [Abstract][Full Text] [Related]
13. Mothers' screening histories influence daughters' vaccination uptake: an analysis of linked cervical screening and human papillomavirus vaccination records in the North West of England.
Spencer Nee Pilkington AM; Brabin L; Verma A; Roberts SA
Eur J Cancer; 2013 Apr; 49(6):1264-72. PubMed ID: 23290788
[TBL] [Abstract][Full Text] [Related]
14. [Vaccination against human papillomavirus. Implementation and efficacy against cervical cancer control].
Bégué P; Henrion R; Blanc B; Girard M; Sancho-Garnier H
Bull Acad Natl Med; 2007 Dec; 191(9):1805-16; discussion 1816-7. PubMed ID: 18663976
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus, cervical cancer, and the vaccines.
Tovar JM; Bazaldua OV; Vargas L; Reile E
Postgrad Med; 2008 Jul; 120(2):79-84. PubMed ID: 18654072
[TBL] [Abstract][Full Text] [Related]
16. Using the theory of planned behavior to predict mothers' intentions to vaccinate their daughters against HPV.
Askelson NM; Campo S; Lowe JB; Smith S; Dennis LK; Andsager J
J Sch Nurs; 2010 Jun; 26(3):194-202. PubMed ID: 20335232
[TBL] [Abstract][Full Text] [Related]
17. Mathematical models of cervical cancer prevention in the Asia Pacific region.
Goldie SJ; Diaz M; Kim SY; Levin CE; Van Minh H; Kim JJ
Vaccine; 2008 Aug; 26 Suppl 12():M17-29. PubMed ID: 18945411
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus vaccine for genotypes 6, 11, 16 and 18: new drug. Cervical cancer prevention: high hopes...
Prescrire Int; 2007 Jun; 16(89):91-4. PubMed ID: 17582921
[TBL] [Abstract][Full Text] [Related]
19. Influence of parent characteristics and disease outcome framing on HPV vaccine acceptability among rural, Southern women.
Sperber NR; Brewer NT; Smith JS
Cancer Causes Control; 2008 Feb; 19(1):115-8. PubMed ID: 17952620
[TBL] [Abstract][Full Text] [Related]
20. Behavioral interventions to increase HPV vaccination acceptability among mothers of young girls.
Cox DS; Cox AD; Sturm L; Zimet G
Health Psychol; 2010 Jan; 29(1):29-39. PubMed ID: 20063933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
